Israel Amirav is an expert in Pulmonology at Tel Aviv Sourasky Medical Center (Israel). As of October 2026, ScienceLeadR ranks Israel Amirav in the top 1% of experts worldwide for Congenital Abnormalities, and in the top 1% of experts in Israel for Ciliary Motility Disorders. Israel Amirav has authored 178 publications, the most recent in 2026, and is an investigator in 10 clinical trials. SLR score: 707 (community average: 125). How the SLR is computed.

LeadR Profile

707 ScienceLeadR Reputation 707
Network Map

Pulmonology

Subspecialties: Pediatrics - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1994 - 2026

Source: PubMed

University of Alberta

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 178

Citations

Citations: 4 637 1st author: 77 Last author: 29 Unique author: 13


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Repurposing adult AI radiograph models for neonatal care through continual learning: an international multicentre study.
PMID 42869977 — privacy, biomedical engineering, learning, artificial intelligence
Nat Biomed Eng20260
Persistent Tachypnea of Infancy (PTI) the Fool?: Insights Into the Management and Long-Term Outcomes of Persistent Tachypnea of Infancy From a Multicenter Cohort Study.
PMID 42264563 — tachypnea, cohort studies
Chest20260
Children's respiratory health risks in the Gaza war: a call to act.
PMID 42034113
Lancet Respir Med Top journal20261
Impact of Home-Based Respiratory Physiotherapy in Nusinersen-Treated Patients with Spinal Muscular Atrophy.
PMID 41770482 — muscular atrophy, atrophy, drug therapy, diagnosis, therapeutics, muscular atrophy, spinal, vital capacity, spine
Adv Ther20260
Risk of small-volume nebulizer treatments in the transmission of bacteria and viruses: a systematic review.
PMID 41518867 — aerosols, viruses, cross infection, pandemics, therapeutics, bacteria, infections
J Hosp Infect20260

Clinical Studies 10

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 10

By status:

Unknown 6
Completed 4

By type:

Observational 9
Interventional 1

By Monocentric/Multicentric:

monocentric 8
multicentric2to4 2
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map